#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Paroxysmal nocturnal haemoglobinuria C3 glomerulopathy Bile acid synthesis disorder Dupuytren's contracture Chronic myeloid leukaemia (in remission) Renal disorder Adrenocortical carcinoma Anti-myelin-associated glycoprotein antibodies positive Anti-neutrophil cytoplasmic antibody positive vasculitis Central nervous system neoplasm Neuroendocrine tumour Homocystinuria Renal cancer metastatic Leukocyte adhesion deficiency type I Glycogen storage disease type I More trials…

    Learn about Rare Diseases

    Leiomyosarcoma recurrent – Basic Information Metachromatic leukodystrophy – Basic Information Mantle cell lymphoma stage IV – Life with Disease Hypereosinophilic syndrome Acquired haemophilia – Treatment KBG syndrome Focal segmental glomerulosclerosis – Treatment Mucopolysaccharidosis II Short-bowel syndrome – Treatment Leiomyosarcoma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Mk-1088 Zamtocabtagene Autoleucel Mva-209-Fsp-B1 Caplacizumab Cortisone Acetate Citric Acid Monohydrate Elivaldogene Autotemcel Metamizole Magnesium Hydrochlorothiazide Warfarin Sodium Izorlisib Mesilate Thiamine Nitrate BMS-986365 Odronextamab GRAPHITE Danazol Zinc Oxide Bepranemab Gemcitabine TRIMIPRAMINE MALEATE More therapies…

    Learn about Your Condition

    Alopecia areata Lung neoplasm malignant Fibrosarcoma Vascular malformation T-cell lymphoma Von Hippel-Lindau disease Anogenital warts Substance use disorder Peritoneal abscess Tardive dyskinesia Follicular lymphoma Ophthalmoplegia Chronic kidney disease Atopic keratoconjunctivitis Cardiac amyloidosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Penile cancer

  • Study on the Effects of Chemotherapy with Paclitaxel, Ifosfamide, and Cisplatin for Patients with Squamous Cell Carcinoma of the Penis and Lymph Node Metastasis

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Penile cancer
    Investigated Drugs:
    • Dexchlorpheniramine Maleate
    • Ranitidine
    • Mesna
    France

  • Study on the Effectiveness of Carboplatin, Paclitaxel, and Pembrolizumab for Patients with Advanced Penile Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Penile cancer
    Investigated Drugs:
    • Carboplatin
    • Paclitaxel
    • Pembrolizumab
    Belgium The Netherlands

  • Study on Using EMI-137 for Intraoperative Visualization in Patients with Penile and Tongue Cancer

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Penile cancer
    • Tongue neoplasm malignant stage unspecified
    Investigated Drugs:
    • Ac-Ala-Gly-Ser-Cys(1)-Tyr-Cys(2)-Ser-Gly-Pro-Pro-Arg-Phe-Glu-Cys(2)-Trp-Cys(1)-Tyr-Glu-Thr-Glu-Gly-Thr-Gly-Gly-Gly-Lys(Unk)-Nh2 Conjugated To Cy5 Dye
    The Netherlands

  • Study on the Use of Indocyanine Green and Technetium (99mTc) Nanocolloid for Sentinel Node Biopsy in Patients with Melanoma, Oral Cancer, or Penile Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Penile cancer
    • Head and neck cancer
    • Malignant melanoma
    Investigated Drugs:
    • Human Albumin Solution
    • Indocyanine Green
    The Netherlands

  • Study of TG4001 and Avelumab for Patients with Advanced HPV-16 Positive Cancers

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Anal cancer
    • Penile cancer
    • Vaginal cancer
    Investigated Drugs:
    • Tipapkinogene Sovacivec
    • Avelumab
    France Spain

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!